Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists), SDF-1 antagonists(C-X-C motif chemokine ligand 12 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 01 May 2005 |